Parmax Pharma Ltd.
BSE: 540359 | Sector: Health care |
NSE: N.A. | ISIN Code: INE240T01014 |
BSE 00:00 | 01 Jul | 32.80 |
0.30 (0.92%) |
OPEN
33.70 |
HIGH
33.70 |
LOW
31.35 |
NSE 05:30 | 01 Jan | Parmax Pharma Ltd |
OPEN | 33.70 |
PREVIOUS CLOSE | 32.50 |
VOLUME | 307 |
52-Week high | 70.90 |
52-Week low | 26.35 |
P/E | 86.32 |
Mkt Cap.(Rs cr) | 12 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Parmax Pharma Ltd. (PARMAXPHARMA) - Financial Ratios
Ratios | 2021 | 2020 | 2019 |
Debt-Equity Ratio | 1.02 | 1.11 | 0.82 |
Current Ratio | 0.88 | 0.89 | 0.92 |
Asset turnover ratio | 2.56 | 2.51 | 1.72 |
Inventory turnover ratio | 7.86 | 6.26 | 3.34 |
Debtors turnover ratio | 10.59 | 9.41 | 7.70 |
Interest Coverage ratio | 4.24 | 6.62 | 4.33 |
Operating Margin (%) | 13.44 | 8.93 | 9.66 |
Net Profit Margin (%) | 2.86 | 2.05 | 0.67 |
Return on Capital Employed (%) | 14.26 | 8.40 | 1.56 |
Return on Net Worth (%) | 13.79 | 8.88 | 1.74 |
Quick Links for Parmax Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices